Ligands & receptors
Types of signaling molecules and the receptors they bind to on target cells. Intracellular receptors, ligand-gated ion channels, G protein-coupled receptors, and receptor tyrosine kinases.
Just as a journey of a thousand miles begins with a single step, so a complex signaling pathway inside of a cell begins with a single key event – the binding of a signaling molecule, or ligand, to its receiving molecule, or receptor.
Receptors and ligands come in many forms, but they all have one thing in common: they come in closely matched pairs, with a receptor recognizing just one (or a few) specific ligands, and a ligand binding to just one (or a few) target receptors. Binding of a ligand to a receptor changes its shape or activity, allowing it to transmit a signal or directly produce a change inside of the cell
Stages of signal transduction: ligand-receptor binding, signal relay, response.
This article focuses on the first stage (signal reception).
In this section, we’ll look at different types of receptors and ligands, seeing how they interact to turn information from outside the cell into a change inside the cell.
Types of receptors
Receptors come in many types, but they can be divided into two categories: intracellular receptors, which are found inside of the cell (in the cytoplasm or nucleus), and cell surface receptors, which are found in the plasma membrane.
Intracellular receptors are receptor proteins found on the inside of the cell, typically in the cytoplasm or nucleus. In most cases, the ligands of intracellular receptors are small, hydrophobic (water-hating) molecules, since they must be able to cross the plasma membrane in order to reach their receptors. For example, the primary receptors for hydrophobic steroid hormones, such as the sex hormones estradiol (an estrogen) and testosterone, are intracellular.
When a hormone enters a cell and binds to its receptor, it causes the receptor to change shape, allowing the receptor-hormone complex to enter the nucleus (if it wasn’t there already) and regulate gene activity. Hormone binding exposes regions of the receptor that have DNA-binding activity, meaning they can attach to specific sequences of DNA. These sequences are found next to certain genes in the DNA of the cell, and when the receptor binds next to these genes, it alters their level of transcription.
Diagram of a signaling pathway involving an intracellular receptor. The ligand crosses the plasma membrane and binds to the receptor in the cytoplasm. The receptor then moves to the nucleus, where it binds DNA to regulate transcription.
Many signaling pathways, involving both intracellular and cell surface receptors, cause changes in the transcription of genes. However, intracellular receptors are unique because they cause these changes very directly, binding to the DNA and altering transcription themselves.
Cell-surface receptors are membrane-anchored proteins that bind to ligands on the outside surface of the cell. In this type of signaling, the ligand does not need to cross the plasma membrane. So, many different kinds of molecules (including large, hydrophilic or "water-loving" ones) may act as ligands.
A typical cell-surface receptor has three different domains, or protein regions: a extracellular ("outside of cell") ligand-binding domain, a hydrophobic domain extending through the membrane, and an intracellular ("inside of cell") domain, which often transmits a signal. The size and structure of these regions can vary a lot depending on the type of receptor, and the hydrophobic region may consist of multiple stretches of amino acids that criss-cross the membrane.
There are many kinds of cell-surface receptors, but here we’ll look at three common types: ligand-gated ion channels, G protein-coupled receptors, and receptor tyrosine kinases.
Ligand-gated ion channels
Ligand-gated ion channels are ion channels that can open in response to the binding of a ligand. To form a channel, this type of cell-surface receptor has a membrane-spanning region with a hydrophilic (water-loving) channel through the middle of it. The channel lets ions to cross the membrane without having to touch the hydrophobic core of the phospholipid bilayer.
When a ligand binds to the extracellular region of the channel, the protein’s structure changes in such a way that ions of a particular type, such as or , can pass through. In some cases, the reverse is actually true: the channel is usually open, and ligand binding causes it to close. Changes in ion levels inside the cell can change the activity of other molecules, such as ion-binding enzymes and voltage-sensitive channels, to produce a response. Neurons, or nerve cells, have ligand-gated channels that are bound by neurotransmitters.
Diagram of a ligand-gated ion channel. When the ligand binds to a closed ion channel in the plasma membrane, the ion channel opens and ions can pass through it, moving into or out of the cell (down their concentration gradient).
G protein-coupled receptors
G protein-coupled receptors (GPCRs) are a large family of cell surface receptors that share a common structure and method of signaling. The members of the GPCR family all have seven different protein segments that cross the membrane, and they transmit signals inside the cell through a type of protein called a G protein (more details below).
GPCRs are diverse and bind many different types of ligands. One particularly interesting class of GPCRs is the odorant (scent) receptors. There are about of them in humans, and each binds its own “scent molecule” – such as a particular chemical in perfume, or a certain compound released by rotting fish – and causes a signal to be sent to the brain, making us smell a smell!
When its ligand is not present, a G protein-coupled receptor waits at the plasma membrane in an inactive state. For at least some types of GPCRs, the inactive receptor is already docked to its signaling target, a G protein.
G proteins come in different types, but they all bind the nucleotide guanosine triphosphate (GTP), which they can break down (hydrolyze) to form GDP. A G protein attached to GTP is active, or “on,” while a G protein that’s bound to GDP is inactive, or “off.” The G proteins that associate with GPCRs are a type made up of three subunits, known as heterotrimeric G proteins. When they’re attached to an inactive receptor, they’re in the “off” form (bound to GDP).
Diagram of the cycle of GPCR signaling.
- When a signaling molecule binds to the GPCR, the G protein alpha subunit exchanges GDP for GTP.
- The alpha subunit dissociates from the beta and gamma subunits and interacts with other molecules, ultimately triggering a cellular response. (The beta and gamma subunits may, in some cases, also participate in signaling.)
- GTP is hydrolyzed to GDP, and the signaling molecule comes off of the receptor.
- The alpha subunit comes back together with the receptor and the beta and gamma subunits.
The cycle can then repeat when a new ligand-binding event takes place.
Ligand binding, however, changes the picture: the GPCR is activated and causes the G protein to exchange GDP for GTP. The now-active G protein separates into two pieces (one called the α subunit, the other consisting of the β and γ subunits), which are freed from the GPCR. The subunits can interact with other proteins, triggering a signaling pathway that leads to a response.
Eventually, the α subunit will hydrolyze GTP back to GDP, at which point the G protein becomes inactive. The inactive G protein reassembles as a three-piece unit associated with a GPCR. Cell signaling using G protein-coupled receptors is a cycle, one that can repeat over and over in response to ligand binding.
G protein-coupled receptors play many different roles in the human body, and disruption of GPCR signaling can cause disease.
Receptor tyrosine kinases
Enzyme-linked receptors are cell-surface receptors with intracellular domains that are associated with an enzyme. In some cases, the intracellular domain of the receptor actually is an enzyme that can catalyze a reaction. Other enzyme-linked receptors have an intracellular domain that interacts with an enzyme.
Receptor tyrosine kinases (RTKs) are a class of enzyme-linked receptors found in humans and many other species. A kinase is just a name for an enzyme that transfers phosphate groups to a protein or other target, and a receptor tyrosine kinase transfers phosphate groups specifically to the amino acid tyrosine.
How does RTK signaling work? In a typical example, signaling molecules first bind to the extracellular domains of two nearby receptor tyrosine kinases. The two neighboring receptors then come together, or dimerize. The receptors then attach phosphates to tyrosines in each others' intracellular domains. The phosphorylated tyrosine can transmit the signal to other molecules in the cell.
Diagram of receptor tyrosine kinases, showing ligand binding and receptor autophosphorylation.
When signaling molecules bind to two nearby receptors, the receptors dimerize (pair up).
The paired receptors phosphorylate one another on tyrosine residues in the intracellular domain (the portion of the protein inside of the cell.
The phosphorylated receptors can interact with other proteins in the cell to trigger signaling pathways leading to a response.
In many cases, the phosphorylated receptors serve as a docking platform for other proteins that contain special types of binding domains. A variety of proteins contain these domains, and when one of these proteins binds, it can initiate a downstream signaling cascade that leads to a cellular response.
Receptor tyrosine kinases are crucial to many signaling processes in humans. For instance, they bind to growth factors, signaling molecules that promote cell division and survival. Growth factors include platelet-derived growth factor (PDGF), which participates in wound healing, and nerve growth factor (NGF), which must be continually supplied to certain types of neurons to keep them alive. Because of their role in growth factor signaling, receptor tyrosine kinases are essential in the body, but their activity must be kept in balance: overactive growth factor receptors are associated with some types of cancers.
Types of ligands
Ligands, which are produced by signaling cells and interact with receptors in or on target cells, come in many different varieties. Some are proteins, others are hydrophobic molecules like steroids, and others yet are gases like nitric oxide. Here, we’ll look at some examples of different types of ligands.
Ligands that can enter the cell
Small, hydrophobic ligands can pass through the plasma membrane and bind to intracellular receptors in the nucleus or cytoplasm. In the human body, some of the most important ligands of this type are the steroid hormones.
Familiar steroid hormones include the female sex hormone estradiol, which is a type of estrogen, and the male sex hormone testosterone. Vitamin D, a molecule synthesized in the skin using energy from light, is another example of a steroid hormone. Because they are hydrophobic, these hormones don’t have trouble crossing the plasma membrane, but they must bind to carrier proteins in order to travel through the (watery) bloodstream.
Chemical structures of estradiol and testosterone. Both have four fused hydrocarbon rings. The two hormones differ in the double bond patterns of the rings and in the functional groups attached to them.
Nitric oxide (NO) is a gas that acts as a ligand. Like steroid hormones, it can diffuse directly across the plasma membrane thanks to its small size. One of its key roles is to activate a signaling pathway in the smooth muscle surrounding blood vessels, one that makes the muscle relax and allows the blood vessels to expand (dilate). In fact, the drug nitroglycerin treats heart disease by triggering the release of NO, dilating vessels to restore blood flow to the heart.
NO has become better-known recently because the pathway that it affects is targeted by prescription medications for erectile dysfunction, such as Viagra.
Ligands that bind on the outside of the cell
Water-soluble ligands are polar or charged and cannot readily cross the plasma membrane. So, most water-soluble ligands bind to the extracellular domains of cell-surface receptors, staying on the outer surface of the cell.
Peptide (protein) ligands make up the largest and most diverse class of water-soluble ligands. For instance, growth factors, hormones such as insulin, and certain neurotransmitters fall into this category. Peptide ligands can range from just a few amino acids long, as in the pain-suppressing enkephalins, to a hundred or more amino acids in length.
Enkephalin: a short peptide ligand of sequence Tyr-Gly-Gly-Phe-Met.
As mentioned above, some neurotransmitters are proteins. Many other neurotransmitters, however, are small, hydrophilic (water-loving) organic molecules. Some neurotransmitters are standard amino acids, such as glutamate and glycine, and others are modified or non-standard amino acids.
Glycine: an amino acid.
Want to join the conversation?
- Why don't hydrophobic ligands get stuck in the membrane? If they're passing through the membrane, then they encounter the hydrophobic space that is the inside of the membrane. If they are also hydrophobic, why do they leave that to continue on into the cell?(19 votes)
- I think one reason is diffusion due to the ligand's concentration gradient. Typically more than one signaling molecule gets released into the environment. If they make it to the hydrophobic portion of the membrane, the next lowest area of concentration would likely be the inside of the cell.(9 votes)
- wouldn't lipid ligands generally be hydrophobic??(6 votes)
- You are correct in the notion that only hydrophobic molecules can ''touch'' eachother for interaction; in a cellular environment however, you usually deal with proteins that contain both hydrophylic and hydrophobic patches due to the characteristics of the amino-acids constituting the protein in question. These patches, together with 3D-structural constraints usually determine possible interactions.
An interesting fact is that the hydrophobic/hydrophylic patches of proteins can be influenced by pH changes (protonation of amino-acids in low pH environments and de-protonation in high pH-environments); this can play an important role in experiments.(22 votes)
- In this, it says 'They [hormones] must bind to carrier proteins in order to travel through the (watery) bloodstream.' The fact that they must bind to carrier proteins implies that otherwise they would repel water. However, hydrophobic molecules are just nonpolar and should still be able to go through water. Why do they [hormones] need to bind to carrier proteins?(3 votes)
- Hydrophobic molecules will most likely precipitate in the watery bloodstream. This way they will accumulate in, obstruct bloodvessels or accumulate in fatty tissues. They also won't be transported as efficiëntly and thus have little to no effect. By binding to carrier proteins they won't precipitate or accumulate in specific places and can do their thing in cells where they are supposed to do their thing.
Hope this helps!
PS. I am not sure if you understand the polar-apolar principle, so here it is in short: polar molecules dissolve in other polar molecules. apolar molecules dissolve in other apolar molecules, but polar molecules generally don't dissolve (or in very, VERY tiny amounts) in apolar molecules (same for apolar in polar).(8 votes)
- So do hydrophobic ligands only bind to intracellular receptors or do they also bind to trans-membrane receptors even though they can diffuse passively across the membrane? Same question for hydrophilic ligands, do they only bind to trans-membrane receptors or do they also bind to intracellular receptors?(5 votes)
- Good question — there are few absolute rules in biology!
For hydrophobic ligands I'll give you examples for steroid hormones — many steroid hormone receptors are found in the cytoplasm and then move into the nucleus once bound by their steroid, while others are always found in the nucleus.
However, recent research has revealed that there are also steroid hormone receptors in the plasma membrane.
I recommend this wikipedia article as a place to start learning more:
While uncommon, there are some hydrophilic ligands that bind to intracellular receptors. One example is the neurotransmitter epinephrine, which also acts as a hormone.
You may find this free online textbook chapter helpful in learning more:
- what are considered kinases: an RTK receptor or an RTK's specialized ligand?(4 votes)
- You find the kinase activity in the receptor itself. But you need a ligand to trigger the dimerization (2 receptors molecules share one ligand) of 2 receptors which only the can act as a proper kinase on each other(5 votes)
- I did not understand what happens after the receptor-hormone complex formation. (From : Intracellular receptors para-2)(3 votes)
- What happens to the ligands after they are received? Do they dissolve and become energy, are released back into the extracellular fluid, or something else entirely?(3 votes)
- Usually they can be re-absorbed and used again. In the case of Calcium, it is reabsorbed.
Nothing in our body is wasted. It either binds reversibly< or become converted to metabolic intermediate.(4 votes)
- How do we know what the ligands are for the different GPCRs? Are there specific assays where we don't have to know the function of the ligand-receptor interaction but can be more accurate than annotating for the ligand-binding amino acids of the GPCR? Seems like there should some sort of holistic-type assay to answer this --which would certainly help with drug discovery!(3 votes)
- Biochemistry investigates amino acids and a closer structure of GPCR receptors.
Once you mention drug discovery, I see where it goes. Ligand-receptor binding could definitely be tracked down and followed (for example, fluorescent tagging of molecules). Nice observation! :D(2 votes)
- since water-soluble messengers bind to receptors situated on the outside of the cell membrane, is it possible for these messengers to influence gene transcription in the cell nucleus(3 votes)
- Yes, it is, by activation of for example MAPK pathways. Cell signaling always includes some cascade and rarely ends up on just one action step.
- Is there a type of ligand that multiple cells are able to receive?(2 votes)
- Yes, there are multifunctioning ligands which bind multiple receptors such as:
influenza virus hemagglutinin trimer binding cell surface glycoproteins on bronchial epithelial cell
multiple receptor-binding sites in all classes of antibodies (IgA. IgG, IgM)